Matches in SemOpenAlex for { <https://semopenalex.org/work/W2512473695> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2512473695 abstract "Antisense oligonucleotide therapy is one of the most promising strategies for treatment of myotonic dystrophy type 1 (DM1), type 2 (DM2) and Duchene muscular dystrophy (DMD). These three diseases have nuclear retained mRNA, suitable for antisense therapy targeting. The delivery of oligonucleotides to their desired target has long been an obstacle in antisense therapy with a large number of delivery reagents or methods having adverse side effects. Promising work published detailing the successful delivery of various chemically modified oligonucleotides (CMOs) naked, via gymnosis, led to us investigating a number of these CMOs: deoxyribonucleic acids (DNA), Peptide nucleic acids (PNAs), 2’OMethyl (2’OMe), and Phosphorodiamidate morpholino (PMO) oligonucleotides. In DM1 expanded CUG repeat (CUGexp) mRNAs aggregate in the nucleus forming “foci”. Testing the CMOs effectiveness at disrupting nuclear foci in a cell based assay, using high content imaging to visualise the number, size and intensity of foci we initially discovered that PNA and 2’OMe, were seemingly taken up via gymnosis by DM1 cells, and removed nuclear foci at nanomolar concentrations. However further experimentation using live cell imaging indicated that although all CMOs could enter the cell, in all disease models tested, via gymnosis, the CMOs could not penetrate the nuclear membrane. In depth analysis led us to identify an artefact of the in-situ process used to identify these foci, explaining earlier positive results. As the target mRNA is trapped within the nuclear compartment we investigated several transfection reagents for their ability to deliver 2’OMe oligonucleotides to the nucleus using live cell fluorescent imaging and a modified northern blot based method. It was established that polyethylenimine could successfully deliver 2’OMe oligonucleotides to the cell, with a high abundance of the oligonucleotide residing within the nuclear compartment. It was observed that PEI degrades the expanded nuclear retained repeat in the DMPK transcript of a DM1 patient cell line alone, without the addition of an antisense agent, in a concentration dependent manner." @default.
- W2512473695 created "2016-09-16" @default.
- W2512473695 creator A5073549084 @default.
- W2512473695 date "2016-07-11" @default.
- W2512473695 modified "2023-09-24" @default.
- W2512473695 title "Investigating the use of oligonucleotides for the treatment of muscular dystrophy" @default.
- W2512473695 hasPublicationYear "2016" @default.
- W2512473695 type Work @default.
- W2512473695 sameAs 2512473695 @default.
- W2512473695 citedByCount "0" @default.
- W2512473695 crossrefType "dissertation" @default.
- W2512473695 hasAuthorship W2512473695A5073549084 @default.
- W2512473695 hasConcept C104317684 @default.
- W2512473695 hasConcept C111599444 @default.
- W2512473695 hasConcept C129312508 @default.
- W2512473695 hasConcept C136571751 @default.
- W2512473695 hasConcept C14363569 @default.
- W2512473695 hasConcept C1491633281 @default.
- W2512473695 hasConcept C153911025 @default.
- W2512473695 hasConcept C185592680 @default.
- W2512473695 hasConcept C24107716 @default.
- W2512473695 hasConcept C2776878037 @default.
- W2512473695 hasConcept C2908938912 @default.
- W2512473695 hasConcept C54009773 @default.
- W2512473695 hasConcept C552990157 @default.
- W2512473695 hasConcept C55493867 @default.
- W2512473695 hasConcept C86803240 @default.
- W2512473695 hasConcept C95444343 @default.
- W2512473695 hasConceptScore W2512473695C104317684 @default.
- W2512473695 hasConceptScore W2512473695C111599444 @default.
- W2512473695 hasConceptScore W2512473695C129312508 @default.
- W2512473695 hasConceptScore W2512473695C136571751 @default.
- W2512473695 hasConceptScore W2512473695C14363569 @default.
- W2512473695 hasConceptScore W2512473695C1491633281 @default.
- W2512473695 hasConceptScore W2512473695C153911025 @default.
- W2512473695 hasConceptScore W2512473695C185592680 @default.
- W2512473695 hasConceptScore W2512473695C24107716 @default.
- W2512473695 hasConceptScore W2512473695C2776878037 @default.
- W2512473695 hasConceptScore W2512473695C2908938912 @default.
- W2512473695 hasConceptScore W2512473695C54009773 @default.
- W2512473695 hasConceptScore W2512473695C552990157 @default.
- W2512473695 hasConceptScore W2512473695C55493867 @default.
- W2512473695 hasConceptScore W2512473695C86803240 @default.
- W2512473695 hasConceptScore W2512473695C95444343 @default.
- W2512473695 hasLocation W25124736951 @default.
- W2512473695 hasOpenAccess W2512473695 @default.
- W2512473695 hasPrimaryLocation W25124736951 @default.
- W2512473695 hasRelatedWork W1502928892 @default.
- W2512473695 hasRelatedWork W1975318829 @default.
- W2512473695 hasRelatedWork W1981701014 @default.
- W2512473695 hasRelatedWork W1982213575 @default.
- W2512473695 hasRelatedWork W2003027481 @default.
- W2512473695 hasRelatedWork W2007404424 @default.
- W2512473695 hasRelatedWork W2009287756 @default.
- W2512473695 hasRelatedWork W2058740371 @default.
- W2512473695 hasRelatedWork W2068368411 @default.
- W2512473695 hasRelatedWork W2083532629 @default.
- W2512473695 hasRelatedWork W2083843089 @default.
- W2512473695 hasRelatedWork W2104723102 @default.
- W2512473695 hasRelatedWork W2186167258 @default.
- W2512473695 hasRelatedWork W2325692787 @default.
- W2512473695 hasRelatedWork W2900920733 @default.
- W2512473695 hasRelatedWork W2973078040 @default.
- W2512473695 hasRelatedWork W2987954841 @default.
- W2512473695 hasRelatedWork W3022930205 @default.
- W2512473695 hasRelatedWork W3048751131 @default.
- W2512473695 hasRelatedWork W2939751630 @default.
- W2512473695 isParatext "false" @default.
- W2512473695 isRetracted "false" @default.
- W2512473695 magId "2512473695" @default.
- W2512473695 workType "dissertation" @default.